Cardio Diagnostics Holdings, Inc.
For the period ended Dec 31, 2025. Filed Mar 13, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 13, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
We do not own any real estate or other physical properties materially important to our operations. We currently maintain our principal executive offices at 311 W. Superior Street, Suite 444, Chicago, IL 60654 pursuant to a three-year lease agreement with an unaffiliated third party that commenced on December 1, 2023. The cost for this space is approximately $13,000 per month. We also maintain a laboratory at 2565 N. Dodge, Suite D, Iowa City, IA 52245 pursuant to a five-year lease agreement with an unaffiliated third party that commenced on December 1, 2023. The cost for this space is approximately $8,505 per month. We consider our current office space, combined with the other office space otherwise available to our executive officers, adequate for our current operations.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.